BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 27060948)

  • 1. Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies.
    Takemoto M; Sato K; Hatanaka N; Yamashita T; Ohta Y; Hishikawa N; Abe K
    J Alzheimers Dis; 2016; 52(1):205-11. PubMed ID: 27060948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
    Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests.
    Chang CC; Liu JS; Chang YY; Chang WN; Chen SS; Lee CH
    Eur J Neurol; 2008 Jan; 15(1):61-5. PubMed ID: 18042240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies.
    Lee JE; Park HJ; Park B; Song SK; Sohn YH; Lee JD; Lee PH
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):320-6. PubMed ID: 19828477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
    Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
    Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Significant Difference in Cognitive Decline and Mortality between Parkinson's Disease Dementia and Dementia with Lewy Bodies: Naturalistic Longitudinal Data from the Swedish Dementia Registry.
    Fereshtehnejad SM; Lökk J; Wimo A; Eriksdotter M
    J Parkinsons Dis; 2018; 8(4):553-561. PubMed ID: 30103351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
    Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
    Aarsland D; Ballard C; Walker Z; Bostrom F; Alves G; Kossakowski K; Leroi I; Pozo-Rodriguez F; Minthon L; Londos E
    Lancet Neurol; 2009 Jul; 8(7):613-8. PubMed ID: 19520613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia.
    Horimoto Y; Matsumoto M; Nakazawa H; Yuasa H; Morishita M; Akatsu H; Ikari H; Yamamoto T; Kosaka K
    J Neurol Sci; 2003 Dec; 216(1):105-8. PubMed ID: 14607310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral Microbleeds in Patients with Parkinson's Disease and Dementia with Lewy Bodies: Comparison Using Magnetic Resonance Imaging and 99 mTc-ECD SPECT Subtraction Imaging.
    Takemoto M; Yamashita T; Ohta Y; Tadokoro K; Omote Y; Morihara R; Abe K
    J Alzheimers Dis; 2021; 80(1):331-335. PubMed ID: 33523013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study.
    Gazzina S; Premi E; Turrone R; Acosta-Cabronero J; Rizzetti MC; Cotelli MS; Gasparotti R; Padovani A; Borroni B
    J Neurol; 2016 Aug; 263(8):1575-82. PubMed ID: 27230856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2010 Apr; 25(5):615-22. PubMed ID: 20175186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
    Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
    Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia.
    Walter U; Dressler D; Wolters A; Wittstock M; Greim B; Benecke R
    J Neurol; 2006 Apr; 253(4):448-54. PubMed ID: 16267638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
    Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mild cognitive impairment stage of dementia with Lewy bodies and Parkinson disease: a comparison of cognitive profiles.
    Yoon JH; Lee JE; Yong SW; Moon SY; Lee PH
    Alzheimer Dis Assoc Disord; 2014; 28(2):151-5. PubMed ID: 24126215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.